Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
112M
-
Number of holders
-
136
-
Total 13F shares, excl. options
-
39.5M
-
Shares change
-
-606K
-
Total reported value, excl. options
-
$230M
-
Value change
-
-$3.96M
-
Put/Call ratio
-
0.37
-
Number of buys
-
46
-
Number of sells
-
-58
-
Price
-
$5.82
Significant Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q3 2020
163 filings reported holding VKTX - Viking Therapeutics, Inc. - COMMON STOCK as of Q3 2020.
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) has 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.5M shares
of 112M outstanding shares and own 35.17% of the company stock.
Largest 10 shareholders include ArrowMark Colorado Holdings LLC (7.99M shares), STATE STREET CORP (5.06M shares), BlackRock Inc. (4.71M shares), VANGUARD GROUP INC (3.31M shares), FMR LLC (1.6M shares), Park West Asset Management LLC (1.46M shares), NORTHERN TRUST CORP (1.39M shares), FIERA CAPITAL CORP (1.13M shares), GEODE CAPITAL MANAGEMENT, LLC (949K shares), and Sio Capital Management, LLC (710K shares).
This table shows the top 136 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.